Alan J. Koletsky
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 4
- Lung Cancer Research Studies 4
-
- Prostate Cancer Treatment and Research 6
- Lung Cancer Treatments and Mutations 5
- Advanced Breast Cancer Therapies 2
- Co-authors
- Mark Allen O’RourkeMohammad JahanzebJoanne MortimerFurhan YunusDavid IrwinJames L. SpeyerPaula KleinLeonard R. Prosnitz
- Journals
- Journal of Clinical Oncology (4 papers)Lung Cancer (2 papers)European Journal of Cancer (2 papers)Annals of Oncology (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United States
In The Last Decade
Alan J. Koletsky
18 papers receiving 426 citations
Peers
Comparison fields: 5 of 48
- Oncology 279
- Pulmonary and Respiratory Medicine 238
- Cancer Research 71
- Radiology, Nuclear Medicine and Imaging 65
- Pathology and Forensic Medicine 47
Countries citing papers authored by Alan J. Koletsky
This map shows the geographic impact of Alan J. Koletsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan J. Koletsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan J. Koletsky more than expected).
Fields of papers citing papers by Alan J. Koletsky
This network shows the impact of papers produced by Alan J. Koletsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan J. Koletsky. The network helps show where Alan J. Koletsky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan J. Koletsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 64 | |
| 2 | 2014 | 4 | |
| 3 | 2014 | 5 | |
| 4 | 2014 | 10 | |
| 5 | Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: a phase II study. | 2004 | 9 |
| 6 | 2003 | 14 | |
| 7 | 2002 | 98 | |
| 8 | Weekly herceptin with navelbine in chemonaïve patients with HER2 positive metastatic breast cancer: A phase II multicenter trial | 2001 | 2 |
| 9 | 2001 | 7 | |
| 10 | 2000 | 3 | |
| 11 | 1999 | 48 | |
| 12 | RATIONALE FOR TRIALS STUDYING PEGYLATED LIPOSOMAL DOXORUBICIN IN METASTATIC BREAST CANCER | 1997 | 3 |
| 13 | 1996 | 100 | |
| 14 | 1995 | 1 | |
| 15 | 1989 | 23 | |
| 16 | Modulation of doxorubicin dox resistance by cyclosporin a csa and a non immunosuppressive homolog | 1987 | 5 |
| 17 | 1986 | 47 | |
| 18 | 1986 | 1 |
About Alan J. Koletsky
Alan J. Koletsky is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Physiology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 18 papers that have together received 444 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Prostate Cancer Treatment and Research (6 papers), Lung Cancer Treatments and Mutations (5 papers), HER2/EGFR in Cancer Research (4 papers), Lung Cancer Research Studies (4 papers), Hormonal and reproductive studies (2 papers), Advanced Breast Cancer Therapies (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Oncology (279 citations), Pulmonary and Respiratory Medicine (238 citations), Cancer Research (71 citations), Radiology, Nuclear Medicine and Imaging (65 citations) and Pathology and Forensic Medicine (47 citations). Alan J. Koletsky has collaborated with scholars based in United States. Frequent co-authors include Mark Allen O’Rourke, Mohammad Jahanzeb, Joanne Mortimer, Furhan Yunus, David Irwin, James L. Speyer, Paula Klein, Leonard R. Prosnitz, Howard Ozer and John Hohneker. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, European Journal of Cancer, Annals of Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.